Acetazolamide Tablet
Product Images NDC 51672-4022

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Acetazolamide (NDC 51672-4022). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Acetazolamide 01)

FDA Label Image

Principal Display Panel (125 mg Tablet Bottle Label)

Principal Display Panel (125 mg Tablet Bottle Label)
This is a medication package for Acetazolamide tablets distributed by Taro Pharmaceuticals. The package contains 100 tablets and should not be used for household dispensing. The tablets should be stored at a temperature between 20° to 25°C. Taro Pharmaceuticals is located in Israel and the USA. This medication is only available with a prescription and should be kept out of reach of children.*
FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Principal Display Panel (250 mg Tablet Bottle Label)
This is a prescription medication with the generic name AcetaZOLAMIDE. The package contains 100 tablets and the National Drug Code is 51672-4023-1. The package is not intended for household dispensing and must be kept out of reach of children. The recommended storage is between 20° to 25°C (68° to T°F). The medication is distributed by Taro Pharmaceuticals in the US and manufactured by Taro Pharmaceutical Industry Ltd in Haifa Bay, Israel. This package includes a usual dosage insert for prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.